These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34848122)

  • 1. Dog/cat-origin quinolone-resistant Streptococcus agalactiae isolates with point mutations in quinolone resistance-determining regions: Relatedness with clonal complex 10.
    Maeda T; Tsuyuki Y; Goto M; Yoshida H; Fujita T; Takahashi T
    J Infect Chemother; 2022 Mar; 28(3):389-395. PubMed ID: 34848122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Quinolone Nonsusceptible Streptococcus canis Strains with Point Mutations in Quinolone Resistance-Determining Regions and Their Related Factors.
    Fukushima Y; Tsuyuki Y; Goto M; Yoshida H; Takahashi T
    Jpn J Infect Dis; 2020 May; 73(3):242-249. PubMed ID: 32009056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.
    Piccinelli G; Gargiulo F; Corbellini S; Ravizzola G; Bonfanti C; Caruso A; De Francesco MA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2466-9. PubMed ID: 25666148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone-resistant phenotype of Flavobacterium columnare isolates harbouring point mutations both in gyrA and parC but not in gyrB or parE.
    Mata W; Putita C; Dong HT; Kayansamruaj P; Senapin S; Rodkhum C
    J Glob Antimicrob Resist; 2018 Dec; 15():55-60. PubMed ID: 29807204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.
    Kawamura Y; Fujiwara H; Mishima N; Tanaka Y; Tanimoto A; Ikawa S; Itoh Y; Ezaki T
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3605-9. PubMed ID: 14576126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-Resistant
    Arias B; Kovacec V; Vigliarolo L; Suárez M; Tersigni C; Müller L; Lopardo H; Bonofiglio L; Mollerach M
    Microb Drug Resist; 2019 Jun; 25(5):739-743. PubMed ID: 30676886
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic mutations in the quinolone resistance-determining region are related to changes in the epidemiological profile of methicillin-resistant Staphylococcus aureus isolates.
    de Oliveira TLR; Cavalcante FS; Chamon RC; Ferreira RBR; Dos Santos KRN
    J Glob Antimicrob Resist; 2019 Dec; 19():236-240. PubMed ID: 31176072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide spread and diversity of mutation in the gyrA gene of quinolone-resistant Corynebacterium striatum strains isolated from three tertiary hospitals in China.
    Wang Y; Shi X; Zhang J; Wang Y; Lv Y; Du X; ChaoLuMen Q; Wang J
    Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):71. PubMed ID: 34598679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal Quinolone Resistance Originated from Several Commensal
    Chen M; Zhang C; Zhang X; Chen M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance.
    Simoni S; Vincenzi C; Brenciani A; Morroni G; Bagnarelli P; Giovanetti E; Varaldo PE; Mingoia M
    Microb Drug Resist; 2018 Apr; 24(3):225-231. PubMed ID: 28783417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.
    Kakinuma Y; Maeda Y; Mason C; Goldsmith CE; Coulter WA; Matsuda M; Dooley JS; Lowery CJ; Moore JE
    Br J Biomed Sci; 2012; 69(3):123-5. PubMed ID: 23057160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
    Jones ME; Critchley IA; Karlowsky JA; Blosser-Middleton RS; Schmitz FJ; Thornsberry C; Sahm DF
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1651-7. PubMed ID: 12019071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
    Shoji H; Shirakura T; Fukuchi K; Takuma T; Hanaki H; Tanaka K; Niki Y
    J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.